Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2001-09-10 | Abraham E. Cohen (65) has been Chairman of the Board since June 1994 and a director since June 1993, and is presently an independent consultant. He retired in 1992 as Senior Vice President of Merck & Co., Inc. |
| 2002-11-13 | Abraham E. Cohen (66) has been Chairman of the Board since June 1994 and a director since June 1993, and is presently an independent consultant. He retired in 1992 as Senior Vice President of Merck & Co., Inc. |
| 2003-09-23 | Mr. Cohen retired in 1992 as Senior Vice President of Merck & Co., Inc. |
| 2004-09-27 | Mr. Cohen is presently an independent consultant. He retired in 1992 as Senior Vice President of Merck & Co., Inc. |
| 2005-09-27 | Mr. Cohen retired in 1992 as Senior Vice President of Merck & Co., Inc., a position he was elected in 1985. |
| 2009-08-21 | He retired in 1992 as Senior Vice President of Merck & Co., Inc., a position he was elected to in 1985. From 1979 to 1989, Mr. Cohen was also President of Merck Sharp & Dohme International, a division of Merck & Co., Inc. Mr. Cohen is a director of the following public companies: Akzo Nobel Nv., Chugai Pharmaceutical Co., Ltd., Neurobiological Technologies, Inc. and Teva Pharmaceutical Industries, Ltd. |
Data sourced from SEC filings. Last updated: 2025-07-16